H.B. Fuller Reports Third Quarter Fiscal Year 2020 Results

·16 mins read

Diluted EPS of $0.79 ; adjusted diluted EPS of $0.76

Adjusted EBITDA of $106 million exceeded guidance range

Debt paydown of $59M ahead of target

ST. PAUL, Minn. , Sept. 23, 2020 /PRNewswire/ -- H.B. Fuller Company (NYSE: FUL) today reported financial results for its third quarter ended August 29, 2020 .

(PRNewsfoto/H.B. Fuller Company)
(PRNewsfoto/H.B. Fuller Company)

Items of Note for Third Quarter 2020

  • Strong operational performance with net income of $42 million and adjusted EBITDA of $106 million , which exceeded the company's guidance, driven by solid organic sales results, benefits from restructuring efficiencies and lower raw material costs.

  • Total organic revenues declined by 2.5% compared with last year, ahead of the company's expectations.

  • Continued share gains led to organic revenue growth in Hygiene, Health and Consumable Adhesives (HHC) and higher sequential revenues in Engineering Adhesives and Construction Adhesives.

  • Year-to-date cash flow from operations increased by 20% versus the same period in 2019, driven by working capital reductions.

  • Debt paydown of $59 million exceeded the company's $40 to $50 million targeted debt paydown for the quarter. The company remains on track to achieve $200 million debt repayment target for 2020.

  • Delivered restructuring savings of $7 million in the quarter, with expected savings of approximately $30 million for fiscal year 2020, related to our realignment to three global business units (GBUs).

  • The company expects to deliver additional savings of $20 to $30 million by the end of 2022 related to the company's operations and supply chain project initiated this year.

Summary of Third Quarter 2020 Results
Net revenue of $691 million decreased 4.7% compared with the third quarter of 2019.  Organic revenue was down 2.5% versus the same period last year, excluding impacts from foreign currency exchange rates and the sale of the surfactants, thickeners and dispersants business which, combined, negatively impacted revenues by 2.2%. Hygiene, Health and Consumable Adhesives organic revenue increased 1% year over year reflecting continued demand for adhesives for essential goods and packaging. Construction Adhesives and Engineering Adhesives organic revenues were lower than last year but increased versus the second quarter. Engineering Adhesives significantly improved revenue performance included double-digit year-over-year growth in Electronics, Recreational Vehicles and Technical Textiles.

Gross profit margin was 27.2%. Adjusted gross profit margin of 27.3% was down 150 basis points versus last year. The decline was due to lower revenues and unfavorable business mix related to impacts from COVID-19, partially offset by favorable raw material costs. Selling, General and Administrative (SG&A) expense was $129 million . Adjusted SG&A expense of $123 million declined 6.4% compared with the same period last year, driven by cost savings realized from the company's business realignment to three global business units and lower discretionary expenses in the quarter.

As a result of these factors, net income attributable to H.B. Fuller in the quarter was $42 million , or $0.79 per diluted share. Adjusted net income attributable to H.B. Fuller was $40 million , or $0.76 of adjusted EPS, down from $44 million , or $0.86 of adjusted EPS in the prior year. Adjusted EBITDA was $106 million in the quarter, compared with $116 million in the same period last year, and adjusted EBITDA margin was 15.3% versus 16% in the prior year.

"In the third quarter, we delivered higher than expected organic revenue performance by building on our market share gains in HHC, improving performance in Construction Adhesives and winning new business in Engineering Adhesives," said Jim Owens , H.B. Fuller president and chief executive officer. "We continued to realize operational cost efficiencies from our GBU realignment, reduce SG&A spending and bring down raw material costs, which drove EBITDA results that were also better than forecasted. Strong cash flow enabled us to exceed our debt paydown target in the quarter, keeping us on track for $200 million of total debt paydown for the year. During the quarter, we also began implementing the operational improvement projects we announced on our second quarter call that will drive $20 to $30 million of incremental cost savings in 2021 and 2022.

Owens continued, "H.B. Fuller has performed well during the pandemic due to the competitive advantages we've created through our new GBU and global customer focused business structure, our cultural emphasis on collaboration and speed and our investments in digital tools. We will build on our successes from the first nine months of the year and leverage those wins in the fourth quarter and into 2021. Our margins and cash flow remain resilient, and we are well-positioned to accelerate our performance as end markets continue to show signs of improvement. We remain focused on our vision to be the best adhesive company in the world by creating value for our customers and shareholders today, and as the world evolves following the pandemic."

Key Balance Sheet and Cash Flow Items
At the end of the third quarter of 2020, the company had cash on hand of $75 million and total debt equal to $1,869 million . This compares to cash and debt levels equal to $70 million and $1,928 million , respectively, at the end of the second quarter of 2020. For the nine-month year-to-date period, cash flow from operations increased to $193 million from $160 million for the same period of 2019, driven by improved working capital management. Capital expenditures were $17 million versus $15 million in the third quarter of fiscal 2019, reflecting timing of capital projects and expenditures related to growth initiatives. The company estimates capital investment for the fiscal year totaling $80 to $85 million

H.B. Fuller has more than adequate liquidity to meet any foreseeable needs, including a $400 million revolving credit facility with a feature that allows for an increase of the facility by $300 million dollars if needed. The company also has ample room under its debt covenants using significantly conservative outlook scenarios. 

Q4 2020 Guidance
The extent of COVID-19's impact on global economic factors remains uncertain. The company is providing the following guidance based on current economic projections, order patterns and assumptions for global commercial activity:

  • Estimated revenue in the fourth quarter is anticipated to increase by 4% to 7% sequentially from the third quarter and be approximately flat to down 3% year over year.

  • Adjusted EBITDA is anticipated to be approximately $110 million to $115 million , in line with the fourth quarter of 2019.

  • Debt reduction of $200 million for the full year, consistent with our original 2020 plans.

Conference Call
The Company will host an investor conference call to discuss its third quarter results and fourth quarter planning assumptions on Thursday, Sept. 24, 2020 , at 10:30 a.m. EDT . The conference call audio and accompanying presentation slides will be available to interested parties via a simultaneous webcast, and may be accessed from the company's website at  https://investors.hbfuller.com/calendar . Participants should access the webcast prior to the start of the call to register for the event and install and test any necessary software. Accompanying presentation slides will be available at the link above 30 minutes prior to the call, and the webcast and presentation will be archived on the company's website. A telephone replay of the conference call will be available approximately 1 hour after the conclusion of the call, through Oct. 1, 2020. To access the telephone replay dial 1-877-344-7529 in the US, 855-669-9658 in Canada , and 1-412-317-0088 outside the US and Canada , and enter access code 10147504.

Regulation G
The information presented in this earnings release regarding segment operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to generally accepted accounting principles (GAAP) and should not be construed as an alternative to the reported results determined in accordance with GAAP. Management has included this non-GAAP information to assist in understanding the operating performance of the company and its operating segments as well as the comparability of results to the results of other companies. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP information is reconciled with reported GAAP results in the "Regulation G Reconciliation" tables in this press release with the exception of our forward-looking non-GAAP measures contained above in our fiscal 2020 Planning Assumptions, which the company cannot reconcile to forward-looking GAAP results without unreasonable effort.

About H.B. Fuller
Since 1887, H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives, sealants and other specialty chemical products to improve products and lives. With fiscal 2019 net revenue of $2.9 billion , H.B. Fuller's commitment to innovation brings together people, products and processes that answer and solve some of the world's biggest challenges. Our reliable, responsive service creates lasting, rewarding connections with customers in electronics, disposable hygiene, medical, transportation, aerospace, clean energy, packaging, construction, woodworking, general industries and other consumer businesses. And, our promise to our people connects them with opportunities to innovate and thrive. For more information, visit us at https://www.hbfuller.com/ .

Safe Harbor for Forward-Looking Statements
Certain statements in this press release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to various risks and uncertainties, including but not limited to the following: the consequences of the COVID-19 outbreak and other pandemics; the substantial amount of debt we have incurred to finance our acquisition of Royal, our ability to repay or refinance it or incur additional debt in the future, our need for a significant amount of cash to service and repay the debt and to pay dividends on our common stock, and the effect of restrictions contained in our debt agreements that limit the discretion of management in operating the business or ability to pay dividends; various risks to stockholders of not receiving dividends and risks to our ability to pursue growth opportunities if we continue to pay dividends according to the current dividend policy; we may be unable to achieve expected synergies, cost savings and operating efficiencies from the Royal transaction, the global business unit realignment or the operations and supply chain project within the expected time frames or at all; we may be unable to successfully integrate Royal's operations into our own, or such integration may be more difficult, time consuming or more costly than expected; the ability to effectively implement Project ONE;  political and economic conditions; product demand; competitive products and pricing; costs of and savings from restructuring initiatives; geographic and product mix; availability and price of raw materials; the company's relationships with its major customers and suppliers; changes in tax laws and tariffs; devaluations and other foreign exchange rate fluctuations; the impact of litigation and environmental matters; the effect of new accounting pronouncements and accounting charges and credits; and similar matters. Many of the foregoing risks and uncertainties are, and will be, exacerbated by COVID-19 and any worsening of the global business and economic environment as a result.

Further information about the various risks and uncertainties can be found in the company's SEC 10-K filing for the fiscal year ended November 30, 2019 . All forward-looking information represents management's best judgment as of this date based on information currently available that in the future may prove to have been inaccurate. Additionally, the variety of products sold by the company and the regions where the company does business make it difficult to determine with certainty the increases or decreases in net revenue resulting from changes in the volume of products sold, currency impact, changes in product mix, and selling prices. However, managements' best estimate of these changes as well as changes in other factors have been included.

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED FINANCIAL INFORMATION

In thousands, except per share amounts (unaudited)












Three Months Ended


Percent of


Three Months Ended


Percent of


August 29, 2020


Net Revenue


August 31, 2019


Net Revenue

Net revenue

$

691,463


100.0%


$

725,376


100.0%

Cost of sales


(503,619)


(72.8%)



(518,055)


(71.4%)

Gross profit


187,844


27.2%



207,321


28.6%











Selling, general and administrative expenses


(129,113)


(18.7%)



(140,615)


(19.4%)

Other income, net


3,722


0.5%



22,762


3.1%

Interest expense


(20,196)


(2.9%)



(25,607)


(3.5%)

Interest income


2,945


0.4%



3,115


0.4%

Income before income taxes and income from equity method investments


45,202


6.5%



66,976


9.2%











Income taxes


(5,112)


(0.7%)



(19,321)


(2.7%)

Income from equity method investments


1,541


0.2%



2,075


0.3%

Net income including non-controlling interest


41,631


6.0%



49,730


6.9%











Net (loss) income attributable to non-controlling interest


(24)


(0.0%)



(12)


(0.0%)

Net income attributable to H.B. Fuller

$

41,607


6.0%


$

49,718


6.9%











Basic income per common share attributable to H.B. Fuller

$

0.80




$

0.98



Diluted income per common share attributable to H.B. Fuller

$

0.79




$

0.97













Weighted-average common shares outstanding:










Basic


52,130





50,939



Diluted


52,591





51,502













Dividends declared per common share

$

0.163




$

0.160



 

Selected Balance Sheet Information (subject to change prior to filing of the Company's Quarterly Report on Form 10-Q)











August 29, 2020


November 30, 2019


August 31, 2019

Cash & cash equivalents

$

74,922


$

112,191


$

119,776

Trade accounts receivable, net


476,099



493,181



485,688

Inventories


354,221



337,267



373,609

Trade payables


272,232



298,869



272,554

Total assets


3,981,725



3,985,734



4,032,683

Total debt


1,868,926



1,979,116



2,097,122

 

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED FINANCIAL INFORMATION

In thousands, except per share amounts (unaudited)












Nine Months Ended


Percent of


Nine Months Ended


Percent of


August 29, 2020


Net Revenue


August 31, 2019


Net Revenue

Net revenue

$

2,012,629


100.0%


$

2,157,894


100.0%

Cost of sales


(1,469,622)


(73.0%)



(1,552,189)


(71.9%)

Gross profit


543,007


27.0%



605,705


28.1%











Selling, general and administrative expenses


(398,620)


(19.8%)



(432,407)


(20.0%)

Other income, net


11,740


0.6%



29,113


1.3%

Interest expense


(64,597)


(3.2%)



(79,354)


(3.7%)

Interest income


8,761


0.4%



9,191


0.4%

Income before income taxes and income from equity method investments


100,291


5.0%



132,248


6.1%











Income taxes


(22,194)


(1.1%)



(38,902)


(1.8%)

Income from equity method investments


5,068


0.3%



5,273


0.2%

Net income including non-controlling interest


83,165


4.1%



98,619


4.6%











Net (loss) income attributable to non-controlling interest


(50)


(0.0%)



(16)


(0.0%)

Net income attributable to H.B. Fuller

$

83,115


4.1%


$

98,603


4.6%











Basic income per common share attributable to H.B. Fuller 1

$

1.60




$

1.94



Diluted income per common share attributable to H.B. Fuller 1

$

1.59




$

1.90













Weighted-average common shares outstanding:










Basic


51,959





50,864



Diluted


52,400





51,836













Dividends declared per common share

$

0.485




$

0.475




1 Income per share amounts may not add due to rounding

 

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

















Three Months Ended


Nine Months Ended



August 29,
2020


August 31,
2019


August 29,
2020



August 31,
2019















Net income attributable to H.B. Fuller


$

41,607


$

49,718


$

83,115



$

98,603

Adjustments:














Acquisition project costs



(55)



1,535



(1,162)




2,158

Organizational realignment



2,511



(684)



6,199




1,110

Royal restructuring and integration



1,358



(9,132)



5,502




(1,150)

Tax reform



-



-



(26)




55

Project ONE



1,216



1,130



3,100




3,179

Other 2



(6,687)



1,660



(3,842)




3,427

Adjusted net income attributable to H.B. Fuller 3



39,950



44,227



92,886




107,382















Add:














Interest expense



20,220



25,607



64,650




79,354

Interest income



(2,945)



(3,115)



(8,761)




(9,191)

Income taxes



14,050



14,798



32,335




37,219

Depreciation and amortization expense 4



34,432



34,606



102,992




105,403

Adjusted EBITDA 3



105,707



116,123



284,102




320,167















Diluted Shares



52,591



51,502



52,400




51,836

Adjusted diluted income per common share attributable to

H.B. Fuller 3


$

0.76


$

0.86


$

1.77



$

2.07

Revenue


$

691,463


$

725,376


$

2,012,629



$

2,157,894

Adjusted EBITDA margin 3



15.3%



16.0%



14.1%




14.8%

_______________















2  Includes adjustment of ($7,182) of discrete tax benefit in the quarter ended August 29, 2020 related to various foreign tax matters and a tax benefit relating to the revaluation of cross-currency swap agreements due to appreciation of the Euro versus US dollar.


3  Adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Adjusted net income attributable to H.B. Fuller is defined as net income before the specific adjustments shown above. Adjusted diluted income per common share is defined as adjusted net income attributable to H.B. Fuller divided by the number of diluted common shares. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation, amortization and the specific adjustments shown above. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net revenue. The table above provides a reconciliation of adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin to net income attributable to H.B. Fuller, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.


4  Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in Adjusted net income attributable to H.B. Fuller totaling ($413) and ($174) for the three months ended August 29, 2020 and August 30, 2019, respectively and ($509) and ($1,135) for the nine months ended August 29, 2020 and August 30, 2019, respectively.

 


H.B. FULLER COMPANY AND SUBSIDIARIES


SEGMENT FINANCIAL INFORMATION


In thousands (unaudited)














Three Months Ended


Nine Months Ended


August 29, 2020


August 31, 2019


August 29, 2020


August 31, 2019

Net Revenue:












Hygiene, Health and Consumable Adhesives

$

320,187


$

328,420


$

977,373


$

986,166

Engineering Adhesives


276,083



286,716



761,040



855,010

Construction Adhesives


95,193



108,406



274,216



302,987

Corporate Unallocated


-



1,834



-



13,731

Total H.B. Fuller

$

691,463


$

725,376


$

2,012,629


$

2,157,894













Segment Operating Income:












Hygiene, Health and Consumable Adhesives

$

31,883


$

32,638


$

89,556


$

85,576

Engineering Adhesives


29,873



36,847



65,386



98,146

Construction Adhesives


4,284



7,650



9,436



14,246

Corporate Unallocated


(7,309)



(10,429)



(19,991)



(24,670)

Total H.B. Fuller

$

58,731


$

66,706


$

144,387


$

173,298













Adjusted EBITDA 3












Hygiene, Health and Consumable Adhesives

$

43,697


$

45,146


$

127,914


$

123,700

Engineering Adhesives


46,831



52,152



112,918



144,521

Construction Adhesives


14,394



17,486



39,893



44,185

Corporate Unallocated


785



1,339



3,377



7,761

Total H.B. Fuller

$

105,707


$

116,123


$

284,102


$

320,167













Adjusted EBITDA Margin 3












Hygiene, Health and Consumable Adhesives


13.6%



13.7%



13.1%



12.5%

Engineering Adhesives


17.0%



18.2%



14.8%



16.9%

Construction Adhesives


15.1%



16.1%



14.5%



14.6%

Corporate Unallocated


NMP



NMP



NMP



NMP

Total H.B. Fuller


15.3%



16.0%



14.1%



14.8%


NMP = non-meaningful percentage


3 Adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Adjusted net income attributable to H.B. Fuller is defined as net income before the specific adjustments shown above. Adjusted diluted income per common share is defined as adjusted net income attributable to H.B. Fuller divided by the number of diluted common shares. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation, amortization and the specific adjustments shown above. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net revenue. The table above provides a reconciliation of adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin to net income attributable to H.B. Fuller, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)











Three Months Ended



Nine Months Ended


August 29, 2020

August 31, 2019



August 29, 2020


August 31, 2019

Income before income taxes and income from

equity method investments

$

45,202


$

66,976



$

100,291



$

132,248

Adjustments:














Acquisition related activity


(73)



1,871




(1,584)




2,641

Organizational realignment


3,308



(1,345)




8,286




885

Royal restructuring and integration


1,790



(12,131)




7,379




(1,591)

Tax reform


-



-




(35)




75

Project ONE


1,602



1,378




4,141




3,982

Other


654



213




1,725




1,105

Adjusted income before income taxes and income from equity method investments 5

$

52,483


$

56,962



$

120,203



$

139,345


5 Adjusted income before income taxes and income from equity investments is a non-GAAP financial measure. Adjusted income before income taxes and income from equity investments is defined as income before income taxes and income from equity investments before the specific adjustments shown above. The table above provides a reconciliation of adjusted income before income taxes and income from equity investments to income before income taxes and income from equity investments, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)
















Three Months Ended



Nine Months Ended


August 29, 2020

August 31, 2019



August 29, 2020


August 31, 2019

Income taxes

$

(5,112)


$

(19,321)



$

(22,194)



$

(38,902)















Adjustments:














Acquisition related activity


18



(336)




423




(482)

Organizational realignment


(797)



660




(2,087)




225

Royal restructuring and integration


(431)



2,999




(1,877)




441

Tax reform


-



-




9




(20)

Project ONE


(386)



(247)




(1,043)




(803)

Other 2


(7,342)



1,447




(5,566)




2,322

Adjusted income taxes 6

$

(14,050)


$

(14,798)



$

(32,335)



$

(37,219)















Adjusted income before income taxes and income from equity method investments

$

52,483


$

56,962



$

120,203



$

139,345

Adjusted effective income tax rate 6


26.8%



26.0%




26.9%




26.7%


2 Includes adjustment of ($7,182) of discrete tax benefit in the quarter ended August 29, 2020 related to various foreign tax matters and a tax benefit relating to the revaluation of cross-currency swap agreements due to appreciation of the Euro versus US dollar.


6 Adjusted income taxes and adjusted effective income tax rate are non-GAAP financial measures. Adjusted income taxes is defined as income taxes before the specific adjustments shown above. Adjusted effective income tax rate is defined as income taxes divided by adjusted income before income taxes and income from equity method investments. The table above provides a reconciliation of adjusted income taxes and adjusted effective income tax rate to income taxes, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)















Three Months Ended


Nine Months Ended


August 29, 2020


August 31, 2019


August 29, 2020



August 31, 2019














Net revenue


691,463



725,376



2,012,629




2,157,894














Gross profit

$

187,844


$

207,321


$

543,007



$

605,705

Gross profit margin


27.2%



28.6%



27.0%




28.1%














Adjustments:













Organizational realignment


(204)



(367)



(53)




(124)

Royal restructuring and integration


1,132



1,741



2,730




4,250

Other


272



(5)



1,263




(9)

Adjusted gross profit 7

$

189,044


$

208,690


$

546,947



$

609,822

Adjusted gross profit margin 7


27.3%



28.8%



27.2%




28.3%


7 Adjusted gross profit and adjusted gross profit margin are non-GAAP financial measures. Adjusted gross profit and adjusted gross profit margin is defined as gross profit and gross profit margin excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted gross profit and gross profit margin to gross profit and gross profit margin, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)















Three Months Ended


Nine Months Ended


August 29, 2020


August 31, 2019


August 29, 2020


August 31, 2019














Selling, general and administrative expenses

$

(129,113)


$

(140,615)


$

(398,620)



$

(432,407)














Adjustments:













Acquisition project costs


(73)



1,871



(1,584)




2,641

Organizational realignment


3,516



2,937



8,342




4,551

Royal restructuring and integration


682



2,737



4,725




10,747

Tax reform


-



-



(35)




75

Project ONE


1,602



1,378



4,142




3,982

Other


382



242



462




1,134

Adjusted selling, general and administrative expenses 8

$

(123,004)


$

(131,450)


$

(382,568)



$

(409,277)

_______________


8 Adjusted selling, general and administrative expenses is a non-GAAP financial measure. Adjusted selling, general and administrative expenses is defined as selling, general and administrative expenses excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted selling, general and administrative expenses to selling, general and administrative expenses, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)























Hygiene,
Health and
Consumable

Adhesives


Engineering

Adhesives


Construction

Adhesives



Total


Corporate

Unallocated


H.B. Fuller

Consolidated


Three Months Ended August 29, 2020









Net income attributable to H.B. Fuller


$

33,688


$

31,334


$

5,468


$

70,490


$

(28,883)


$

41,607


Adjustments:




















Acquisition project costs



-



-



-



-



(55)



(55)


Organizational realignment



-



-



-



-



2,511



2,511


Royal restructuring and integration



-



-



-



-



1,358



1,358


Project ONE



-



-



-



-



1,216



1,216


Other



-



-



-



-



(6,687)



(6,687)


Adjusted net income attributable to

H.B. Fuller 3



33,688



31,334



5,468



70,490



(30,540)



39,950


Add:




















Interest expense



-



-



-



-



20,220



20,220


Interest income



-



-



-



-



(2,945)



(2,945)


Income taxes



-



-



-



-



14,050



14,050


Depreciation and amortization expense



10,009



15,497



8,926



34,432



-



34,432


Adjusted EBITDA 3

$


43,697


$

46,831


$

14,394


$

104,922


$

785


$

105,707


Revenue



320,187



276,083



95,193



691,463



-



691,463


Adjusted EBITDA Margin 3



13.6%



17.0%



15.1%



15.2%



NMP



15.3%
























Hygiene,
Health and
Consumable

Adhesives


Engineering

Adhesives


Construction

Adhesives



Total


Corporate

Unallocated


H.B. Fuller

Consolidated


Nine Months Ended August 29, 2020









Net income attributable to H.B. Fuller


$

94,979


$

69,767


$

12,987


$

177,733


$

(94,618)


$

83,115


Adjustments:




















Acquisition project costs



-



-



-



-



(1,162)



(1,162)


Organizational realignment



-



-



-



-



6,199



6,199


Royal restructuring and integration



-



-



-



-



5,502



5,502


Tax reform



-



-



-



-



(26)



(26)


Project ONE



-



-



-



-



3,100



3,100


Other



-



-



-



-



(3,842)



(3,842)


Adjusted net income attributable to

H.B. Fuller 3



94,979



69,767



12,987



177,733



(84,847)



92,886


Add:




















Interest expense



-



-



-



-



64,650



64,650


Interest income



-



-



-



-



(8,761)



(8,761)


Income taxes



-



-



-



-



32,335



32,335


Depreciation and amortization expense



32,935



43,151



26,906



102,992



-



102,992


Adjusted EBITDA 3

$


127,914


$

112,918


$

39,893


$

280,725


$

3,377


$

284,102


Revenue



977,373



761,040



274,216



2,012,629



-



2,012,629


Adjusted EBITDA Margin 3



13.1%



14.8%



14.5%



13.9%



NMP



14.1%



Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.


NMP = Non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)






















Hygiene,
Health and
Consumable

Adhesives


Engineering

Adhesives


Construction

Adhesives



Total


Corporate

Unallocated


H.B. Fuller

Consolidated

Three Months Ended August 31, 2019








Net income attributable to H.B. Fuller


$

33,934


$

38,014


$

8,662


$

80,610


$

(30,892)


$

49,718

Adjustments:



















Acquisition project costs



-



-



-



-



1,535



1,535

Organizational realignment



-



-



-



-



(684)



(684)

Royal Restructuring



-



-



-



-



(9,132)



(9,132)

Project ONE



-



-



-



-



1,130



1,130

Other



-



-



-



-



1,660



1,660

Adjusted net income attributable to

H.B. Fuller 3



33,934



38,014



8,662



80,610



(36,383)



44,227

Add:



















Interest expense



-



-



-



-



25,607



25,607

Interest income



-



-



-



-



(3,115)



(3,115)

Income taxes



-



-



-



-



14,798



14,798

Depreciation and amortization expense



11,212



14,138



8,824



34,174



432



34,606

Adjusted EBITDA 3


$

45,146


$

52,152


$

17,486


$

114,784


$

1,339


$

116,123




















Revenue



328,420



286,716



108,406



723,542



1,834



725,376

Adjusted EBITDA Margin 3



13.7%



18.2%



16.1%



15.9%



NMP



16.0%






















Hygiene,
Health and
Consumable

Adhesives


Engineering

Adhesives


Construction

Adhesives



Total


Corporate

Unallocated


H.B. Fuller

Consolidated

Nine Months Ended August 31, 2019








Net income attributable to H.B. Fuller


$

89,567


$

101,476


$

17,228


$

208,271


$

(109,668)


$

98,603

Adjustments:



















Acquisition project costs



-


-

-


-

-


-

-



2,158



2,158

Organizational realignment



-


-

-


-

-


-

-



1,110



1,110

Royal Restructuring



-


-

-


-

-


-

-



(1,150)



(1,150)

Tax Reform



-


-

-


-

-


-

-



55



55

Project ONE



-


-

-


-

-


-

-



3,179



3,179

Other



-


-

-


-

-


-

-



3,427



3,427

Adjusted net income attributable to

H.B. Fuller 3



89,567



101,476



17,228



208,271



(100,889)



107,382

Add:



















Interest expense



-



-



-



-



79,354



79,354

Interest income



-



-



-



-



(9,191)



(9,191)

Income taxes



-



-



-



-



37,219



37,219

Depreciation and amortization expense



34,133



43,045



26,957



104,135



1,268



105,403

Adjusted EBITDA 3

$


123,700


$

144,521


$

44,185


$

312,406


$

7,761


$

320,167




















Revenue



986,166



855,010



302,987



2,144,163



13,731



2,157,894

Adjusted EBITDA Margin 3



12.5%



16.9%



14.6%



14.6%



NMP



14.8%


Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.


NMP = non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

SEGMENT FINANCIAL INFORMATION

NET REVENUE GROWTH (DECLINE)

(unaudited)



















Three Months
Ended

Nine Months
Ended














August 29, 2020













Price


(0.4%)


(0.7%)













Volume


(2.1%)


(3.1%)













Organic Growth (Decline)


(2.5%)


(3.8%)













M&A


(0.2%)


(0.6%)













F/X


(2.0%)


(2.3%)













Total H.B. Fuller net revenue


(4.7%)


(6.7%)

















































Three Months Ended


Nine Months Ended



August 29, 2020


August 29, 2020



Net
Revenue


F/X


M&A


Organic
Growth
(Decline)


Net
Revenue


F/X


M&A


Organic
Growth
(Decline)


















Hygiene, Health and Consumable Adhesives


(2.5%)


(3.6%)


0.0%


1.1%


(0.9%)


(3.6%)


0.0%


2.7%

Engineering Adhesives


(3.7%)


(0.8%)


0.0%


(2.9%)


(11.0%)


(1.5%)


0.0%


(9.5%)

Construction Adhesives


(12.2%)


0.0%


0.0%


(12.2%)


(9.5%)


(0.3%)


0.0%


(9.2%)

Unallocated Corporate


NMP


0.0%


NMP


0.0%


NMP


0.0%


NMP


0.0%

Total H.B. Fuller


(4.7%)


(2.0%)


(0.2%)


(2.5%)


(6.7%)


(2.3%)


(0.6%)


(3.8%)


NMP =non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)


(Unaudited)









August 29,



November 30,



2020



2019

Assets





Current assets:






Cash and cash equivalents

$ 74,922


$

112,191


Trade receivables (net of allowances of $13,637 and $10,682, as of August 29, 2020 and November 30, 2019, respectively)

476,099



493,181


Inventories

354,221



337,267


Other current assets

84,187



90,723

Total current assets

989,429



1,033,362








Property, plant and equipment

1,392,017



1,304,231


Accumulated depreciation

(737,299)



(674,418)

Property, plant and equipment, net

654,718



629,813








Goodwill

1,306,398



1,281,808


Other intangibles, net

771,942



799,399


Other assets

259,238



241,352

Total assets

$ 3,981,725


$

3,985,734







Liabilities, non-controlling interest and total equity





Current liabilities:






Notes payable

$ 21,082


$

15,732


Current maturities of long-term debt

-



65,000


Trade payables

272,232



298,869


Accrued compensation

68,031



78,582


Income taxes payable

18,352



23,229


Other accrued expenses

75,739



60,745

Total current liabilities

455,436



542,157








Long-term debt, excluding current maturities

1,847,844



1,898,384


Accrued pension liabilities

84,336



80,214


Other liabilities

280,201



242,190

Total liabilities

$ 2,667,817



$ 2,762,945







Equity:





H.B. Fuller stockholders' equity:






Preferred stock (no shares outstanding) shares authorized – 10,045,900

-



-


Common stock, par value $1.00 per share, shares authorized – 160,000,000, shares outstanding – 51,725,732 and 51,241,190, as of August 29, 2020 and November 30, 2019, respectively

51,726



51,241


Additional paid-in capital

149,305



130,295


Retained earnings

1,442,292



1,384,411


Accumulated other comprehensive loss

(329,932)



(343,600)


Total H.B. Fuller stockholders' equity

1,313,391



1,222,347

Non-controlling interest

517



442

Total equity

1,313,908



1,222,789

Total liabilities, non-controlling interest and total equity

$ 3,981,725


$

3,985,734

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

In thousands (Unaudited)





Nine Months Ended





August 29, 2020


August 31, 2019

Cash flows from operating activities:








Net income including non-controlling interest


$

83,165


$

98,619

Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:








Depreciation



50,558



50,269


Amortization



52,943



56,269


Deferred income taxes



(10,952)



(36,831)


Income from equity method investments, net of dividends received



2,660



1,743


Loss (gain) on sale of assets



118



(19,964)


Share-based compensation



14,087



20,170


Change in assets and liabilities, net of effects of acquisitions:







Trade receivables, net



17,307



(15,674)



Inventories



(17,195)



(17,704)



Other assets



31,372



(31,853)



Trade payables



(9,449)



2,246



Accrued compensation



(12,345)



(10,173)



Other accrued expenses



8,776



7,936



Income taxes payable



330



23,587



Accrued / prepaid pensions



(5,954)



(7,548)



Other liabilities



20,481



10,636


Other



(32,872)



28,520

Net cash provided by operating activities



193,030



160,248










Cash flows from investing activities:








Purchased property, plant and equipment



(71,939)



(47,023)


Purchased businesses, net of cash acquired



(9,500)



(8,042)


Purchase of assets



(5,623)



-


Purchased business remaining equity



-



(9,870)


Proceeds from sale of property, plant and equipment



1,407



5,314


Proceeds from sale of business



-



70,293


Cash received from government grant



-



9,045


Cash payments related to government grant



(5,326)



(1,120)

Net cash (used in) provided by investing activities



(90,981)



18,597